Breakthrough Properties Purchases Biomanufacturing Facility in Everett for $78 Million

Breakthrough Properties, a premier global life science real estate developer, today announced it has acquired a recently delivered biomanufacturing facility at 215 Shuksan Way in Everett, Washington, just outside of Seattle. In 2024, shortly after acquiring Seagen, Pfizer shut down the facility at this location, backing out of a 20-year lease. Breakthrough, a joint venture […]